Parkman Healthcare Partners’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,203,484
| Closed | -$7.03M | – | 98 |
|
|
2022
Q4 | $7.03M | Buy |
1,203,484
+65,897
| +6% | +$385K | 1.87% | 15 |
|
|
2022
Q3 | $7.62M | Buy |
1,137,587
+13,515
| +1% | +$90.6K | 2.17% | 15 |
|
|
2022
Q2 | $4.73M | Buy |
1,124,072
+746,673
| +198% | +$3.14M | 1.74% | 21 |
|
|
2022
Q1 | $1.27M | Buy |
+377,399
| New | +$1.27M | 0.37% | 59 |
|
|
2021
Q1 | – | Sell |
-50,290
| Closed | -$636K | – | 100 |
|
|
2020
Q4 | $636K | Buy |
+50,290
| New | +$636K | 0.16% | 79 |
|